US authorities have given the green light to a new drug against Alzheimer’s disease, expanding the treatment options available to people in the early stages of brain decline. The U.S. Food and Drug Administration (FDA) has approved Eli Lilly’s donanemab. The drug is sold under the brand name Kisunla. This comes just weeks after a … Read more
A groundbreaking Alzheimer’s drug has been approved in the United States that slows mental decline by up to 60 percent. Donanemab, sold in the US under the brand name Kisunla, is available for patients with early symptoms of the disease. In Alzheimer’s disease, two proteins accumulate that cause brain cells to dieSource: AP The drug … Read more
Credit: Pixabay/CC0 public domain Years after questions were raised about their integrity, two of the University of Minnesota’s most prominent scientific discoveries have been retracted in the space of one week: one that offered hope for the therapeutic potential of stem cells and the other that offered a promising path to treating Alzheimer’s disease. The … Read more
Years after questions were raised about their integrity, two of the University of Minnesota’s most prominent scientific discoveries have been retracted within a week: one that offered hope for the therapeutic potential of stem cells and another that offered a promising path to treating Alzheimer’s disease. The studies are more than a decade old and … Read more
Researchers will no longer have to choose between studying a single human brain as a patchwork of fragmented images or a distant, pixelated representation of large structures. A new imaging platform developed by a US team instead seamlessly combines the finer details of brain cells, their connections and contents, with brain-wide maps of entire networks … Read more